on behalf of the National Cardiovascular Data's ICD Registry Background-The majority of current implantable cardioverter-defibrillator (ICD) recipients are significantly older than those in the ICD trials. Data on periprocedural complications among the elderly are insufficient. We evaluated the influence of age on perioperative complications among primary prevention ICD recipients in the United States. Methods and Results-Using the National Cardiovascular Data's ICD Registry, we identified 150 264 primary prevention patients who . The primary end point was any adverse event or in-hospital mortality. Secondary end points included major adverse events, minor adverse events, and length of stay. Of 150 264 patients, 61% (nϭ91 863) were 65 years and older. A higher proportion of patients Ն65 years had diabetes, congestive heart failure, atrial fibrillation, renal disease, and coronary artery disease. Approximately 3.4% of the entire cohort had any complication, including death, after ICD implant. Any adverse event or death occurred in 2.8% of patients under 65 years old; 3.1% of 65-to 69-year-olds; 3.5% of 70-to 74-year-olds; 3.9% of 75-to 79-year-olds, 4.5% of 80-to 84-year-olds; and 4.5% of patients 85 years and older. After adjustment for clinical covariates, multivariate analysis found an increased odds of any adverse event or death among 75-to 79-year-olds (1.14 [95% confidence interval, 1.03 to 1.25], 80-to 84-year-olds (1.22 [95% confidence interval, 1.10 to 1.36], and patients 85 years and older (1.15 [95% confidence interval, 1.01 to 1.32], compared with patients under 65 years old. Conclusions-Older patients had a modestly increased-but acceptably safe-risk of periprocedural complications and in-hospital mortality, driven mostly by increased comorbidity. (Circ Cardiovasc Qual Outcomes. 2011;4:549-556.)
implantable cardioverter-defibrillator (ICD) therapy among the elderly, [1] [2] [3] [4] recent studies have found that ICDs are effective in reducing total mortality in all age groups. [5] [6] [7] With the number of US individuals over age 65 projected to reach 72 million by 2030, 8, 9 the number of elderly patients eligible for ICD therapy will increase severalfold over the next 2 decades. Already, the average age of the ICD recipient is 68 years, 10 -11 with approximately 40% of recipients being 70 years and older at implant. 12 Data on complication rates are needed to help older patients make an informed decision about the risks and benefits with ICD implantation. However, few studies have adequately examined the question. Patients of advanced age were underrepresented in the large primary prevention ICD trials (mean age, 60 to 65 years), 4, [13] [14] [15] and cohort studies of elderly recipients have been limited to single centers, 16 -21 outdated databases, 7,16 -18,20 -22 or patients outside of the United States. 16 -19 With the advent of newer and smaller ICDs, 23 the complication rates associated with ICD implantation reported from the older databases 7,16 -18 may be inaccurate. In addition, the influence of age on implantation complications may be continuous across the age groups. Past studies used only one age cut-off to define elderly patients, 7,16 -18,24 even though sexagenarians may have complication rates different from those of septuagenarians or octogenarians.
To determine the current rates of ICD complications among advanced-age ICD recipients in different decades of life across different communities in the United States, we describe the influence of age on ICD implantation-related complications and mortality using a national registry of patients undergoing ICD implant for primary prevention.
formed in response to a mandate from the Centers of Medicare and Medicaid Services (CMS) with the purpose of characterizing primary prevention ICD recipients. Although implanting institutions are required to enter data only from Medicare beneficiaries, the majority of institutions register all ICD recipients, regardless of indication or insurance status. 25 Institutions use a standardized questionnaire to submit clinical information, such as baseline patient clinical characteristics, device used, and in-hospital outcomes on a quarterly basis. Only hospitals achieving Ͼ95% completeness of specific data elements were included in the data analysis. The rate of missing values was Ͻ1% for all variables except left ventricular ejection fraction (LVEF). The data are subject to quality-control checks of missing or improperly coded items. 26 
WHAT IS KNOWN
• Although approximately 40% of recipients are 70 years or older at implant, implantable cardioverterdefibrillator complication rates among advancedaged patients are unknown.
WHAT THE STUDY ADDS
• Differences in complication rates among older patients were found. • In unadjusted analyses, the occurrence of any adverse event or in-hospital death increased from 2.8% in the youngest age group (under 65 years of age) to 4.5% in the oldest age groups (80 years and older). • After multivariate adjustment, advanced age was associated with only a modestly increased risk of periprocedural complications and in-hospital death. • Comorbid conditions were as important, of even more so, than age in determining complication risks.
Study Population
All patients within the NCDR-ICD Registry who had undergone ICD implantation between January 2006 to December 2008 were included if they received an ICD implantation for primary prevention. This study excluded patients who had received ICDs for secondary prevention (history of syncope, cardiac arrest, or sustained ventricular tachycardia) to avoid potential underreporting by institutions, or had received a prior ICD.
Independent Variables
The primary independent variable was age, categorized into 5 groups: Ͻ65, 65 to 69, 70 to 74, 75 to 79, 80 to 84, and at least 85 years old. We categorized age because it was not linearly associated with outcomes. We also examined the following clinical variables in the multivariate model: (1) 
Dependent Variables
The occurrence of any adverse event (major or minor adverse event) or death was considered the primary end point. Secondary end points included major adverse events, minor adverse events, and length of hospital stay. Adverse events were reported by implanting centers using standard definitions (online-only Supplement Appendix) and were defined as any major or minor event that occurred during or after ICD implant up until the time of discharge. Major adverse events were defined as cardiac arrest, cardiac perforation, cardiac valve injury, coronary venous dissection, hemothorax, pneumothorax, deep phlebitis, transient ischemic attack, stroke, MI, pericardial tamponade, lead dislodgment, and arterial-venous fistula. Minor adverse events were defined as drug reaction, conduction block, hematoma, peripheral embolus, superficial phlebitis, peripheral nerve injury, and infection related to device.
Statistical Analysis
To identify significant patient, physician, and hospital factors associated with our primary and secondary end points, we used hierarchical logistic regression models or multilevel models-which adjust for patient clustering within hospitals-to evaluate the relationship between age and any adverse event or death. Our initial analysis was unadjusted for other characteristics. We repeated the analysis after sequentially adjusting for patient clinical characteristics, physician certification, and hospital characteristics. Confounding factors included in the model were demographic, clinical, procedure, and physician characteristics listed in Tables 1 and 2 . We used Markov chain Monte Carlo multiple imputation procedure 27 to impute missing values with assumptions that the data were missing at random, and the parameters of the data model and of the missing data indicators were distinct. The statistical level of 0.05 was used for significance. All analyses were performed using the SAS statistical package version 9.2 (SAS Institute, Cary, NC). All analyses were approved by the Yale University Human Investigation Committee.
Results

Study Population
We identified 333 993 patients who underwent ICD implantation from January 2006 to December 2008. We excluded 32 767 patients who had received a prior ICD; 119 435 patients who had received ICDs for secondary prevention; and 31 527 patients from hospitals that had submitted data only on Medicare beneficiaries. The final study group consisted of 150 264 patients. Figure 1 illustrates the distribution of ICD implantations among the age groups. Of 150 264 patients, 61% (nϭ91 863) were 65 years and older. The average age of the cohort was 67Ϯ13 years. Among patients 65 years and older, patients 70 to 79 years made up the largest age subgroups (15.1%, 70 to 74 years and 15.4%, 75 to 79 years); 65-to 69-year-old patients represented 14.5% of the total ICD population, 80-to 84-year-olds represented 11.3%, and Ն85-year-olds represented 4.8%. Table 1 describes the characteristics of the ICD recipients. As expected, the proportion of patients with more advanced NYHA heart failure class and ischemic cardiomyopathy increased with age. Patients Ն65 years old had a higher frequency of diabetes, atrial fibrillation, and renal disease. Approximately one-quarter (27%) of recipients were women, a proportion that only modestly changed with age. The majority of patients were hospitalized electively for device implantation, whereas the remainder of patients received ICDs after being hospitalized for other cardiac or noncardiac issues; the latter occurred more frequently with age.
Clinical Characteristics of the Study Group
Otherwise, only clinically modest differences were observed among the age groups in measures of timing of MI to ICD implant, QRS duration, type of physician performing the ICD implant, hospital type, and geographic location. Tables 1  and 2 summarize the clinical, physician, and hospital characteristics of the study population by age group. Figure 2 shows the crude adverse event and mortality rates for each age group; 5068 patients (3.4%) had any adverse event or death. Of the total events (nϭ5359), minor events comprised 61% (nϭ3244). The rates of any adverse or death varied across the age groups. Patients under 65 years old had the lowest rates of any events, including death, (2.8%), followed by 65-to 69-year-olds (3.1%), then 70-to 74-yearolds (3.5%), and then 75-to 79-year-olds (3.9%). Once patients reached 80 years of age, the rate of any events, including mortality, reached a plateau (4.5%, 80-to 84-years and 4.5%, Ն85 years). In-hospital mortality rates only modestly increased with age.
Perioperative Complications
Exclusive of death, the frequencies of major and minor adverse events varied with age, with minor events comprising the majority of events. Among all the complications, hematoma was the most common. A higher frequency of pneumothorax, MI, pericardial tamponade, hemothorax, and hematoma were observed with age. Otherwise, the rates of drug reaction, cardiac valve injury, lead dislodgment, peripheral nerve injury, peripheral embolus, transient ischemic attack, stroke, AV fistula, and device-related infections appeared similar across ages. Table 3 describes the adverse event rates in each age group.
Using patients under 65 years old as the reference group, in the hierarchical model, which adjusted only for clustering and However, age was a weaker predictor of complications, compared with sex, renal failure, stage IV heart failure, 2 nd -or 3 rd -degree AV block, atrial fibrillation, biventricular ICD place-ment, hospitalizations not primarily for device implant, and physician certification. Besides device type, the strongest predictor for periprocedural complications was ICD implantation by a thoracic surgeon (odds ratio, 1.49 [95% CI 1.24 to 1.79]), compared with board-certified electrophysiologists. Table 4 describes the predictors of any adverse events or death after ICD implantation.
Impact on Length of Hospital Stay
The overall median length of stay was 1 [1, 4] days. Although median length of stay was different among the age groups, clinically significant differences were modest (Table 3) . Among patients electively admitted for device implantation, the median length of stay was 1 [1, 4] days for patients under 65 years of age, 1 [1, 3] 65 to 69 years of age, 1 [1, 4] 70 to 74 years of age, 1 [1, 4] 75 to 79 years of age, 1 [1, 5] 80 to 84 years of age, and 1 [1, 6] for patients 85 years and older. Similarly, for urgent cardiac and noncardiac admissions, despite variations in length of stay with age, clinically significant differences were modest.
Discussion
We evaluated the rate of ICD implantation-related complications, using a national registry of the largest population of older patients to date, and found differences in complication rates among older patients. In analyses without adjustment for clinical characteristics, the occurrence of any adverse event or in-hospital death increased from 2.8% in the youngest age group (under 65 years of age) to 4.5% in the oldest age groups (80 years and older). After multivariate adjustment, advanced age was associated with only a modestly increased risk of periprocedural complications and in-hospital death. Comorbid conditions were as important, or even more so, than age in determining complication risks.
With the aging population, it is not surprising that the average age of the current ICD recipient is above 65 years of age. 11, 12 However, other comorbidities may also increase with age and predispose patients to procedural complications. Prior studies have reported ICD complication rates as high as 10% to 40%, 7,16 -18,22 making some physicians weary of referring their elderly patients for ICD implant. 28 In our study, we found low complication rates-fewer than 5%even for individuals older than 80 years of age. Despite the older average age of these patients (age, 67 years), and their multiple risk variables, these patients performed similarly to patients in the ICD trials, 4, 13, 29 who were on average 5 to 10 years younger, and had fewer comorbidities. The patients probably benefitted from having received ICDs in recent years 30 -when operators had already gained significant experience with ICD implantation and that the majority of these patients were implanted by electrophysiologists. 30 Notably, despite trends in underreferral of older patients for ICD implantation, [31] [32] we still found that a significant proportion of current ICD recipients were older. Almost half (46%) of the patients were 70 years and older, and more than 15% were 80 years and older, confirming the rapidly expanding demographic of elderly ICD recipients. Such observations are consistent with reports from the ACT Registry, 12 a national registry of patients with St Jude devices. Our study extends the observations from the ACT study by including all current ICD recipients in the US and providing a real-world evaluation in a large cohort. The numbers of elderly ICD recipients will only to continue to grow in the coming years, 9, 33 and they probably will require more biventricular devices than the standard ICDs. Given the technical challenge associated with biventricular devices, the trend of decreasing ICD complications 30 is unlikely to continue.
We observed that for all age groups, the majority of complications were minor. These minor complications did not appear to meaningfully impact length of stay, or significantly increase in-hospital mortality. However, the effect on quality of life could not be measured in our study and perhaps can be addressed in future studies. Overall length of stay, median d*
One important finding of our study was the identification of multiple cardiac and noncardiac conditions, besides age, that increase perioperative complications. Consistent with prior investigations, 11, 30, 34, 35 we found that female sex, those who received ICDs with cardiac resynchronization therapy, and device implantation by nonelectrophysiologists were associated with higher perioperative complications, and were even stronger predictors of complications than advance age. Comorbidities, including end-stage renal disease, stage IV heart failure, atrial fibrillation, and advanced heart block, were also stronger predictors of complications than advanced age. Consistent with clinical experience, we found that patients who received ICDs in the latter portion of a hospitalization precipitated by cardiac and noncardiac reasons were more likely to have complications than patients hospitalized primarily for device implant, an observation reflecting the higher morbidity of the former group of patients. These findings confirm clinical experience that patients should not be excluded from ICD consideration, based on age alone. Clinicians must weigh the number and severity of comorbid conditions-both observed here and perhaps, some not captured in our dataset-even more so than age when deciding the potential complication risks in older patients.
Interestingly, although women tend to live longer and their risk of coronary heart disease increases with age, 36 the proportion of female ICD recipients did not increase with age. This observation appears to support observations of ICD underutilization among women 37 and probably are multifactorial. Potential explanations include more stringent application of ICD guidelines to women, 38 higher complication rates among women, 30, 34 or presentation of women with coronary disease at an older age (and with more comorbidities), leading to a higher threshold for referral.
Finally, few data are available on the impact of age on length of stay after ICD implant. Similar to other types of procedures, 39 we found that age was associated with a longer length of stay. However, the differences were clinically modest. Among patients electively hospitalized for device implantation-which was a more meaningful representation of device-related morbidity-these differences were clinically insignificant. The lack of clinically meaningful variations in hospital stay likely reflected the low rates of major events and deaths overall, and in each of the age groups.
Our study had several limitations. First, the data were obtained from a national database that required mandatory enrollment only of Medicare beneficiaries. Therefore, to generate a study cohort representative of the community, we confined analysis to hospitals who submitted data on both Medicare and non-Medicare beneficiaries. Second, we examined only in-hospital complications and mortality. We were unable to capture complications, such as infection or lead failure, which develop after hospital discharge. However, evaluating this early time window allowed us to evaluate complication rates related to implantation, which are important for decision-making. Third, we did not include lead complications (except lead dislodgment), given the short follow-up, but instead a comprehensive list of other implantation-related adverse events was evaluated. Finally, our database consisted only of patients who had received ICD implants. Potentially, not all the preselection factors may have been captured by the covariates in the dataset. Complication rates depend on patient case selection, and we cannot exclude the possibility that complication rates were decreased in practice because ICD use was restricted to seemingly healthier, older adults. Nevertheless, our dataset has broad representativeness for actual ICD use in older adults. It includes near-complete data on the large number of ICD recipients over age 65 nationally, and rates are probably up to date and accurate, since these rates are not publicly reported and centers had little incentive to underreport adverse events.
Conclusions
Our study offers a real-world evaluation of ICD implantationrelated complications among the US elderly. After adjusting for various clinical, device-related, and operator characteristics, patients 75 years and older have an increased, but acceptably safe, risk of periprocedural complications, including in-hospital mortality, some of which is explained by observed comorbidity and some perhaps by unobserved comorbidity. Nevertheless, these results should not preclude elderly patients from receiving ICDs, but provide much needed information for elderly patients who are eligible for ICD therapy, so that an individualized decision can be reached.
